Detalhe da pesquisa
1.
In Vivo Assessment of Astrocyte Reactivity in Patients with Progressive Supranuclear Palsy.
Ann Neurol
; 2024 May 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38771066
2.
Altered Brain Energy Metabolism Related to Astrocytes in Alzheimer's Disease.
Ann Neurol
; 2023 Sep 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37703428
3.
An optimized reference tissue method for quantification of tau protein depositions in diverse neurodegenerative disorders by PET with 18F-PM-PBB3 (18F-APN-1607).
Neuroimage
; 264: 119763, 2022 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36427751
4.
First-in-human in vivo imaging and quantification of monoacylglycerol lipase in the brain: a PET study with 18F-T-401.
Eur J Nucl Med Mol Imaging
; 49(9): 3150-3161, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35022846
5.
A Machine Learning-Based Approach to Discrimination of Tauopathies Using [18 F]PM-PBB3 PET Images.
Mov Disord
; 37(11): 2236-2246, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36054492
6.
In vivo binding of a tau imaging probe, [11 C]PBB3, in patients with progressive supranuclear palsy.
Mov Disord
; 34(5): 744-754, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30892739
7.
Tau-induced focal neurotoxicity and network disruption related to apathy in Alzheimer's disease.
J Neurol Neurosurg Psychiatry
; 89(11): 1208-1214, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29884723
8.
Correction to: Firstinhuman in vivo imaging and quantification of monoacylglycerol lipase in the brain: a PET study with 18FT401.
Eur J Nucl Med Mol Imaging
; 49(9): 3299, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35403863
9.
PBB3 imaging in Parkinsonian disorders: Evidence for binding to tau and other proteins.
Mov Disord
; 32(7): 1016-1024, 2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-28568506
10.
High-Contrast Imaging of α-Synuclein Pathologies in Living Patients with Multiple System Atrophy.
Mov Disord
; 37(10): 2159-2161, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36041211
11.
Apathy correlates with prefrontal amyloid ß deposition in Alzheimer's disease.
J Neurol Neurosurg Psychiatry
; 85(4): 449-55, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24133289
12.
Imaging of amyloid deposition in human brain using positron emission tomography and [18F]FACT: comparison with [11C]PIB.
Eur J Nucl Med Mol Imaging
; 41(4): 745-54, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24233004
13.
Investigating neural dysfunction with abnormal protein deposition in Alzheimer's disease through magnetic resonance spectroscopic imaging, plasma biomarkers, and positron emission tomography.
Neuroimage Clin
; 41: 103560, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38147791
14.
Misfolded protein deposits in Parkinson's disease and Parkinson's disease-related cognitive impairment, a [11C]PBB3 study.
NPJ Parkinsons Dis
; 10(1): 96, 2024 May 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38702305
15.
In vivo PET classification of tau pathologies in patients with frontotemporal dementia.
Brain Commun
; 6(2): fcae075, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38510212
16.
Imaging α-synuclein pathologies in animal models and patients with Parkinson's and related diseases.
Neuron
; 2024 May 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38843838
17.
ß-Amyloid in Lewy body disease is related to Alzheimer's disease-like atrophy.
Mov Disord
; 28(2): 169-75, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23225334
18.
Two pathways differentially linking tau depositions, oxidative stress, and neuronal loss to apathetic phenotypes in progressive supranuclear palsy.
J Neurol Sci
; 444: 120514, 2023 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36473346
19.
A short-scan method for k(3) estimation with moderately reversible PET ligands: application of irreversible model to early-phase PET data.
Neuroimage
; 59(4): 3149-58, 2012 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22079452
20.
Functional brain imaging of cognitive dysfunction in Parkinson's disease.
J Neurol Neurosurg Psychiatry
; 83(10): 963-9, 2012 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-22807560